Spike Protein–Mediated Compound Immunodeficiency Cascade in COVID-19 and Long-COVID

Abstract

Five years after the emergence of SARS-CoV-2, converging clinical evidence reveals a progressive compound immunodeficiency affecting a substantial and growing proportion of the global population. This manuscript presents a systematic, source-agnostic framework identifying ten interconnected layers of immune degradation driven by persistent spike protein exposure from both viral infection and vaccination [1,2].

We delineate eight primary mechanisms of immunodeficiency: (I) bone marrow HSPC invasion and hematopoietic disruption, (II) decimation of secondary lymphoid organs, (III) persistent spike protein in PBMCs with Th1/Th2 dysregulation, (IV) multi-level Type I interferon suppression, (V) microbiome destruction affecting the gut–immune axis, (VI) T cell exhaustion with syncytial formation and NK cell impairment, (VII) variant-driven expansion of immune evasion, and (VIII) autoimmune paradox through anti-idiotype antibodies and molecular mimicry [1,2,4,5,6,7,8].

Beyond receptor-mediated entry, we describe a multi-layered intracellular damage cascade: mitochondrial hijacking with viral dsRNA enrichment in mitochondria, OXPHOS suppression, and inhibited mitophagy [24,25,27,28,36].; viroporin-mediated calcium dysregulation activating the NLRP3 inflammasome [31,32,39,40].; direct and paracrine cellular senescence propagating through SASP-mediated bystander effects [16,19,20,21,22].; and heritable epigenetic reprogramming of HSPCs that persists for up to one year and is conveyed through differentiation to progeny immune cells [3,43,44,45].

We further present a systematic receptor mapping analysis of fifteen SARS-CoV-2 entry receptors across twenty-seven immune cell types, revealing that long-term hematopoietic stem cells (LT-HSCs) express the highest ACE2 levels of any hematopoietic cell (10–65% of purified HSCs), placing the source of all immune cells at the apex of the vulnerability hierarchy [61,62,63]. Spike protein triggers NLRP3 inflammasome-mediated pyroptosis and suppresses colony-forming capacity in HSPCs [61,63]. The unified escape mutation theory demonstrates that antibody-driven selection has simultaneously expanded receptor tropism beyond ACE2, enabling variants to target immune cells from stem cell to mature effector through redundant alternative pathways [1,2]. ACE2-enhanced late Omicron variants (LP.8.1, NB.1.8.1) disproportionately target the highest-ACE2 population—HSCs—cutting off immune cell supply at the source across all lineages. The analysis reveals an ‘activation trap’ whereby immune response upregulates receptors (CD147, DPP4, TfR1, GRP78) that render responding T cells vulnerable [12,14]. Eight empirically testable predictions are derived from the integrated model.